Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Novus Medical Detox Center Highlights Survey Findings: More Americans Support Detox and Rehab Over Methadone as Treatment for Heroin Addiction
  • USA - English


News provided by

JoTo PR

Mar 31, 2015, 08:00 ET

Share this article

Share toX

Share this article

Share toX

Novus Medical Detox Center comments on a new survey that reveals half of Americans agree that eliminating all drug use is the better option during treatment for substance abuse.
Novus Medical Detox Center comments on a new survey that reveals half of Americans agree that eliminating all drug use is the better option during treatment for substance abuse.

New Port Richey, FL (PRWEB) March 31, 2015 -- According to a recent YouGov/Huffington Post survey on heroin addiction treatment, half of all Americans interviewed supported detox and abstinence, while only 19% were in favor of treatment with synthetic opioids like methadone.(1) Although many within the healthcare community advocate for “medically assisted treatment” with synthetic opioids, the survey findings suggest that most Americans concur with Novus Medical Detox Center that detox and abstaining from future drug use is a better approach than prescribing other drugs.

High-dose methadone ultimately makes the recovery process that much harder for an individual and attempting to withdraw ‘cold turkey’ at that point could kill them.

Post this

The YouGov/Huffington Post survey presented respondents with two opiate treatment options—one where addicts are provided with FDA-approved synthetic opioids under medical supervision versus one where addicts attend Narcotics Anonymous meetings and detox completely from all drugs—and found that more Americans felt detox was the better program. The same poll also revealed that 40% of respondents agreed “synthetic drugs are more dangerous than helpful,” while only 24% opined they were “more helpful than dangerous.”(1)

In a follow-up article to the survey, Huffington Post writers referred to medically assisted treatment with synthetic opioids as “the standard of care for opiate treatment” and derided abstinence as a “broken method.” The article further claimed that 90% of heroin addicts following the abstinence method will relapse, though it didn’t address relapse rates for other methods. (2)

Despite such assertions, Novus’ experience has shown that its detox programs have a high success rate, both among former heroin users as well as those who subsequently become addicted to methadone. “Treating substance abuse with more drugs is not a viable long-term solution, as it often simply replaces one addiction with another,” stated Kent Runyon, Executive Director of Novus Medical Detox Center. He notes that many people develop a tolerance to methadone and other prescription opioids, and have to take increasingly higher dosages to achieve the same effect. “High-dose methadone ultimately makes the recovery process that much harder for an individual and attempting to withdraw ‘cold turkey’ at that point could kill them.”

Runyon maintains that the high relapse rates associated with drug abstinence are not a direct reflection of the approach itself, but are generally due to other factors such as the “hit-or-miss” quality of some detox and drug rehab programs as well as insufficient time devoted to the process. “The fact is that the longer the time a patient spends in rehab directly increases the recovery rate and reduces the relapse rate. There are countless thousands of people who have overcome opiate addiction without touching a single drop of methadone. And as many patients can attest, detoxing from methadone at any dose can be more difficult than trying to get off heroin in the first place,” added Runyon.

Mortality statistics published by the U.S. Centers for Disease Control and Prevention (CDC) reveal that despite a sharp rise in heroin overdose deaths in 2013, twice as many people died from prescription opioid overdoses as from heroin.(3) Another CDC report analyzed methadone specifically and estimated that some 5,000 people die from methadone-related overdoses each year.(4) Runyon contends that the risk of addiction and overdose from synthetic opioids is a strong argument in favor of drug-free treatment programs.

Rather than treating opiate dependency with methadone, buprenorphine or Suboxone, Novus offers medically supervised detox programs that ease patients through the withdrawal process with natural supplements, nutrient-enriched IV treatments, and 24/7 access to nursing care and withdrawal specialists. The customized treatment programs follow proven medical protocols, and patients who require further support are referred to well-screened, quality drug rehab facilities. For those individuals who attempted prescription opioid treatment only to find themselves dependent on another drug, Novus offers methadone and Suboxone detox programs—and even takes on high-dose cases that other facilities refuse.

For more information on Novus Medical Detox Center and its opiate/opioid treatment programs, visit http://www.novusdetox.com.

About Novus Medical Detox Center:
Novus Medical Detox Center is a Joint Commission Accredited inpatient medical detox facility that offers safe, effective alcohol and drug treatment programs in a home-like residential setting. Located on 3.25 tree-lined acres in New Port Richey, Florida, Novus is also licensed by the Florida Department of Children and Families and is known for minimizing the discomfort of withdrawal from prescription medication, drugs or alcohol by creating a customized detox program for each patient. By incorporating medication, natural supplements and fluid replenishment, Novus tailors the detox process for each patient, putting the dignity and humanity back into drug detoxification. Patients have 24/7 medical supervision, including round-the-clock nursing care and access to a withdrawal specialist, and enjoy comfortable private or shared rooms with a telephone, cable television and high-speed Internet access. Novus’ expansion is tied to their contribution to their industry and their local community, ranking number 48 on the Tampa Bay Business Journal’s 2014 Fast 50 Awards list of the fastest-growing companies in Tampa Bay, and number 2,936 on the 2014 Inc. 500/5000 list of fastest-growing companies in America. For more information, visit http://www.novusdetox.com.

1. Moore. Peter. “Poll Results: Heroin” in Huffington Post polls on YouGov; January 20, 2015. today.yougov.com/news/2015/01/20/poll-results-heroin/

2. Grim, Ryan and Ariel Edwards-Levy. “Science Be Damned: Americans Prefer Broken Method Of Heroin Treatment, Survey Finds”; Huffington Post; February 23, 2015. today.yougov.com/news/2015/01/20/poll-results-heroin/

3. National Institute on Drug Abuse. Overdose Death Rates; February 2015. drugabuse.gov/related-topics/trends-statistics/overdose-death-rates

4. Centers for Disease Control and Prevention. “Prescription Painkiller Overdoses: Use and Abuse of Methadone as a Painkiller”; CDC Vital Signs; July 2012. cdc.gov/vitalsigns/pdf/2012-07-vitalsigns.pdf

Karla Jo Helms, JoTo PR, +1 (888) 202-4614 Ext: 802, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.